US-based Inocras Inc. and Summit Pharmaceuticals International Corporation have signed a Memorandum of understanding (Mo...
In an insightful interview with BioSpectrum Asia, Shaun Rothwell, CEO of EVŌQ Nano, reveals the transformative potentia...
Volpara Health, a South Korea-based Lunit company and a global leader in software for the early detection of cancer, has...
South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has secured a s...
4baseCare, an Illumina Accelerator Company, that offers cutting-edge precision oncology solutions using advanced genomic...
Oncomine Dx Target Test to Identify Patients Eligible for Servier’s VORANIGO® (vorasidenib) tablet, the only F...
HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...
South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has announced i...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...
Acer Medical, based in Taiwan, has announced that its artificial intelligence (AI)-assisted bone mineral density abnorma...
GE HealthCare and Roche have entered a strategic collaboration to enhance cancer treatment outcomes and access to precis...
This exciting forum will gather the field to discuss the latest advancements in NGS, biomarker development, clinical tri...
Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, has announced the...
Paris-based Curium, a world leader in nuclear medicine, has entered into a strategic partnership with PDRadiopharma Inc,...
A landmark study led by Duke-NUS Medical School in Singapore has revealed that despite the recent pandemic, outbreak det...
Trinity Biotech plc , a commercial-stage biotechnology company focused on human diagnostics and diabetes management solu...
Mediwhale, an artificial intelligence (AI)-powered health diagnostics startup, has announced $12 million series A2 inves...
Qiagen has announced the expansion of its strategic partnership with Bio-Manguinhos/Fiocruz, the leading provider of vac...